Page last updated: 2024-12-11
hexanitrostilbene
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
hexanitrostilbene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 5462985 |
SCHEMBL ID | 700147 |
MeSH ID | M0512964 |
Synonyms (30)
Synonym |
---|
stilbene, 2,2',4,4',6,6'-hexanitro- |
benzene,1'-(1,2-ethenediyl)bis[2,4,6-trinitro- |
nsc-76741 |
1,2-ethenediyl)bis(2,4,6-trinitrobenzene) |
nsc76741 |
HNS , |
2,4,4',6,6'-hexanitrostilbene |
stilbene,2',4,4',6,6'-hexanitro- |
1,3,5-trinitro-2-[(e)-2-(2,4,6-trinitrophenyl)ethenyl]benzene |
inchi=1/c14h6n6o12/c21-15(22)7-3-11(17(25)26)9(12(4-7)18(27)28)1-2-10-13(19(29)30)5-8(16(23)24)6-14(10)20(31)32/h1-6h/b2-1+ |
ysibqulrfxitsw-owojbtedsa- |
AKOS005606609 |
1,1'-(e)-ethene-1,2-diylbis(2,4,6-trinitrobenzene) |
STK695193 |
unii-5bv4wu3kb3 |
benzene, 1,1'-(1,2-ethenediyl)bis(2,4,6-trinitro- |
jd-x |
einecs 243-494-5 |
nsc 76741 |
2,2',4,4',6,6'-hexanitrostilbene |
1,1'-(1,2-ethenediyl)bis(2,4,6-trinitrobenzene) |
hexanitrostilbene |
hexanitrostilbene [un0392] [explosive 1.1d] |
un0392 |
5bv4wu3kb3 , |
1,1'-(1,2-ethenediyl)bis[2,4,6-trinitrobenzene] |
SCHEMBL700147 |
1,3,5-trinitro-2-[(e)-2-(2,4,6-trinitrophenyl)ethenyl]benzene # |
YSIBQULRFXITSW-OWOJBTEDSA-N |
1,3,5-trinitro-2-[(1e)-2-(2,4,6-trinitrophenyl)ethenyl]benzene |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 31.23
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (31.23) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |